 role aluminum functional iron deficiency patients erythropoietin case report clinical characteristics response treatment quantitative variation patients response part factors anemia patients end-stage renal disease Aluminum effect erythropoietin part iron bioavailability inhibitory effect aggressive ferrotherapy aluminum chelation therapy patient hematological evidence aluminum excess erythropoietin biochemical evidence functional iron deficiency response chelation therapy support hypothesis inhibitory effect aluminum erythropoiesis interference aluminum bioavailability iron